Navigation Links
High Lipoprotein Levels Can Cause Heart Disease
Date:12/23/2009

Study shows it could be a new target for prevention and treatment

WEDNESDAY, Dec. 23 (HealthDay News) -- A genetic study proves that high blood levels of the fat-carrying molecule called lipoprotein(a) can cause heart disease.

"The case for lipoprotein(a) as a direct cause of coronary artery disease is now firm," said Martin Farrall, a professor of cardiovascular genetics at the University of Oxford in England and senior author of a report in the Dec. 24 issue of the New England Journal of Medicine.

Elevated blood levels of LPA, as it is often abbreviated, have been linked to an increased risk of heart disease and other cardiovascular problems for decades, but the evidence has not been definitive. So while an elevated low-density lipoprotein (LDL) cholesterol level remains the most clearly established indicator of coronary risk, "our paper, by genetic research, shows that LPA plays an important role as well," Farrall said.

"Our results will not perhaps surprise some researchers, but the scale of this project and confidence in our results mean that we can move forward to study the details of LPA and coronary risk," he added.

It is a pivotal finding, said Dr. Sekar Kathiresan, director of preventive cardiology at Massachusetts General Hospital, who wrote an accompanying editorial. "Many things in medicine are associated with an increased risk of heart attack. Almost all of these associations are not of a causal nature. This brings LPA into the domain of causal factors. And if it is causal, that gives hope that reducing it can reduce the risk of heart attack," he said. "

"We are now honing in on a potential therapeutic target," Kathiresan stated.

LPA is a member of the family of molecules that carry LDL cholesterol, the "bad" kind that clogs arteries, in the blood. The most common such molecule is lipoprotein(b), which consists of LDL with one protein attached. LPA is different because it has an additional protein attached.

The study done by Farrall and his colleagues looked in exquisite detail at the genetic makeup of 3,145 people with coronary artery disease and 3,352 free of coronary disease. The study of more than 48,000 variants of 2,100 genes found that two variants affecting LPA levels were strongly associated with coronary disease.

"We speculate and anticipate that our finding may carry over to other cardiovascular diseases, such as some kinds of stroke," Farrall said.

The reason for the harmful effects of LPA is unknown, he said. "A number of speculative mechanisms have been proposed," Farrall said. "Our study doesn't help resolve those."

One immediate impact of the research could be widened use of a blood test for LPA, which has been available for years, Kathiresan said. "This kind of study shows that people who carry a genetically determined high level of LPA have an increased risk, and this will likely increase enthusiasm for measuring LPA blood levels, particularly for people who have heart disease at an early age or have a strong family history of heart disease," he said.

And while at least one available drug, niacin, is known to reduce LPA levels to some extent, "we need a drug that selectively reduces LPA," Kathiresan said. "There is some effort to do that."

A major controlled trial will be needed to show that an LPA-lowering drug reduces the incidence of coronary disease, he added.

One odd sidelight is that while participants in the new study -- and most previous trials -- were white Europeans, elevated LPA levels are more common among people from Africa and southern Asia, Kathiresan noted. Studies of those populations are needed, he stressed.

More information

An introduction to the world of lipoproteins is provided by the American Heart Association.



SOURCES: Martin Farrall, professor, cardiovascular genetics, University of Oxford, England; Sekar Kathiresan, director, preventive cardiology, Massachusetts General Hospital, and assistant professor, medicine, Harvard Medical School, Boston; Dec. 24, 2009, New England Journal of Medicine


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. A High-Density Lipoprotein Raising Drug That Has a Lower Discontinuation Rate Than That of Extended Release Niaspan Would Earn a 20 Percent Patient Share in the Dyslipidemia Drug Market
2. Lipoprotein Levels May Predict Womens Hypertension Risk
3. Adult offspring of parents with PTSD have lower cortisol levels
4. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
5. Screening Proposed for Childhood Cholesterol Levels
6. Womens Folic Acid Levels Improving
7. Giving emergency nurses aromatherapy massages with music dramatically reduced stress levels
8. Giving emergency nurses aromatherapy massages with music dramatically reduced stress levels
9. School, family and community involvement are all needed to increase the activity levels of adolescen
10. High HDL Levels Protect Heart Health
11. Meta-Analysis of Blood Phe Levels and Clinical Outcomes in PKU Published
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... ... Cifolelli has joined the company as Vice President of Sales. Cifolelli’s primary ... and international sales in the rapidly expanding field of organizational social engineering. ...
(Date:5/24/2016)... ... May 24, 2016 , ... i2i, ... identity and website at its “Transforming Outcomes” User Conference in Las Vegas on ... i2i’s ongoing success to set the market standard for meaningful population health management. ...
(Date:5/24/2016)... ... May 24, 2016 , ... Educational opportunities, ... housing, with more advantaged communities providing richer opportunities. Recognizing the key role of ... school improvement policies; (b) school choice policies; (c) school desegregation policies; (d) wealth-focused ...
(Date:5/24/2016)... Georgia (PRWEB) , ... May 24, 2016 , ... Mental ... 1969 by the Church of Scientology and renowned professor of psychiatry Thomas Szasz, is ... of its “Psychiatry: An Industry of Death” exhibit in Atlanta, Georgia. The opening of ...
(Date:5/24/2016)... NY (PRWEB) , ... May 24, 2016 , ... ... treatment for physical disease or injury that focuses on repairing the musculoskeletal and ... , With an emphasis on functional restoration, NYDNRehab began providing treatments for physical ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... LAWRENCE, Mass. , May 24, 2016  NxStage ... medical technology company focused on advancing renal care, today ... Officer, plans to participate in the following schedule of ... will be made available at http://ir.nxstage.com/ . ... Jefferies Healthcare Conference NY, NY           Friday, ...
(Date:5/24/2016)... May 24, 2016  Joe Marziani has joined VMS BioMarketing as senior vice president ... today. In his new role, Marziani will lead the company,s business development and sales ... improve outcomes. Photo - http://photos.prnewswire.com/prnh/20160523/371089 ... ... ...
(Date:5/24/2016)... , May 24, 2016 ... doble terapia del mundo, introduce catéteres para la ... OrbusNeich, una compañía global especializada en el ... ha expandido su cartera incluyendo productos para tratar ... y Scoreflex™ PTA son los dispositivos de primera ...
Breaking Medicine Technology: